CHEERS-AI Economic Evaluation

By João L. Carapinha

November 5, 2024

NICE (National Institute for Health and Care Excellence) introduces CHEERS-AI! It’s a new reporting standard optimized for health economic evaluations of AI technologies in healthcare. The EU funded CHEERS-AI as part of the Next Generation Health Technology Assessment (HTx) project. Its primary aim is to enhance the transparency and quality of cost-effectiveness studies specifically tailored for AI-enabled healthcare interventions.

Purpose and Background

CHEERS-AI seeks to systematically address the challenges facing health economic evaluations of AI interventions. A systematic review has identified several issues, including poor quality input data, author conflicts of interest, lack of transparent reporting, and vague information regarding AI functionality.

Solution: CHEERS-AI economic evaluation

Building on the established CHEERS 2022 standards, CHEERS-AI incorporates the original 28 standards while adding 8 new details for AI-related nuances and 10 AI-specific standards. The extra standards tackle key aspects such as user autonomy, continuous AI learning, and the methodology behind developing the AI component.

Objectives

The primary goal of CHEERS-AI is to ensure transparent and reproducible reporting of AI-specific details in health economic evaluations. This standard will aid healthcare decision-makers in understanding the value of AI-enabled treatments, ultimately facilitating faster access to promising AI technologies for patients.

Endorsement and Integration

ISPOR endorsed CHEERS-AI and is now included in the EQUATOR Network checklist of reporting guidelines. This endorsement ensures integration into best practices for health economic evaluation reporting.

Impact

Refining the quality and transparency of health economic evaluations involving AI technologies is an important objective. In doing so, CHEERS-AI aims to elevate the standards of economic evaluation reporting. This improvement is vital for reimbursement decisions and the broader adoption of AI in healthcare.

In summary, CHEERS-AI represents an advancement in standardizing and enhancing health economic evaluations of AI technologies, thereby supporting improved decision-making in healthcare.

Reference url

Recent Posts

endometrial cancer research
       

Endometrial Cancer Treatment Innovations

🔍 Are you aware of the latest advancements in endometrial cancer treatment?

Check out the article “Endometrial Cancer Advances” from Dana-Farber Cancer Institute, highlighting critical findings in hormonal therapy, immunotherapy, and targeted treatments. With 68,000 new cases annually, it’s crucial we stay informed and support the research driving better outcomes for patients.

#SyenzaNews #oncology #clinicaltrials #innovation #healthcare

R21 malaria vaccine DRC
    

DRC Launches R21 Malaria Vaccine to Combat Child Mortality

🌍 How can the introduction of the R21 malaria vaccine transform public health in the Democratic Republic of the Congo?

The DRC has taken a monumental step in the fight against malaria, introducing the R21 vaccine to protect vulnerable populations, particularly young children. Supported by key partners like WHO and UNICEF, this initiative aims to significantly reduce the malaria burden, which currently affects millions. Discover how this rollout, alongside a comprehensive malaria strategy, can change the landscape of public health in the region.

#SyenzaNews #GlobalHealth #HealthcareInnovation #MalariaVaccine #PublicHealth

Oman healthcare development
             

Oman Healthcare Development: A Vision for Self-Reliance and Innovation

🏥 How is Oman revolutionising its healthcare sector?

Our latest article explores the ambitious Vision 2040 aiming to enhance accessibility and quality within Oman’s healthcare system. Discover how the focus on pharmaceutical self-reliance, local production capabilities, and biotechnology is set to transform public health outcomes and stimulate economic growth. Dive in to learn about the exciting initiatives in Oman’s journey toward sustainable healthcare development!

#SyenzaNews #Oman #HealthcareInnovation #EconomicEvaluation #Pharmaceuticals

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.